Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.    

Eviana Health Corporation’s aim is to deliver customized consumer skin care products using natural hemp strains of cannabis sativa for cosmeceutical and nutraceutical merchandise and cannabinoid-based topical creams and products.

EXMceuticals (“EXM”) is a bio-science company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with the ambition to become one of the world's suppliers of highest-grade cannabis ingredients. EXM is currently creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry.

Feel Foods Ltd. is an agri-services company aimed at providing turnkey services to makers, bakers and growers.  Feel Foods is in the process of building out a commercial commissary kitchen that will be available to on site growers as well as local makers, bakers and growers producing small batch artisanal food products.

FinCanna Capital Corp. is a royalty company for the licensed medical cannabis industry which invests in sizable and scalable best-in-class businesses. The Issuer’s business objective is to provide capital solutions to companies in the medical cannabis industry with large scale potential, a highly skilled and experienced operator, which plan to produce high value, high demand licensed medical products or related products and services.  

Fiore Cannabis Ltd. is a U.S. Multi-State Operator running a state-of-the-art cultivation and production facility in Nevada and an award-winning dispensary focused on cannabis wellness products in California.  Fiore has active Cultivation & Production operations in Las Vegas (APEX facility) and a boutique dispensary in California's Coachella Valley (Green Leaf Wellness in Desert Hot Springs). Fiore's proprietary cultivation methodologies maximize the potential for our unique genetic library of organic cannabis strains, resulting in award-winning cannabis retail products such as our Fiore flower and Diamante concentrates.

Flower One is the largest cannabis cultivator, producer and full-service brand fulfillment partner in the state of Nevada. Flower One's fully operational flagship 400,000 square-foot greenhouse and 55,000 square-foot production facility is used for cannabis cultivation, processing, production and manufacturing of dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals and infused products. The Company also operates a 25,000 square-foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and a state of the art commercial kitchen that will produce several of the industry’s top performing edible brands. Leveraging its scale and more than 20 years of greenhouse operational excellence, Flower One offers consistent, reliable, high-volume, and just-in-time fulfillment to a growing number of established cannabis brands. The Company is fully licensed for both recreational and medical marijuana cultivation and production in the state of Nevada.

Flower One is the largest cannabis cultivator, producer and full-service brand fulfillment partner in the state of Nevada. Flower One's fully operational flagship 400,000 square-foot greenhouse and 55,000 square-foot production facility is used for cannabis cultivation, processing, production and manufacturing of dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals and infused products. The Company also operates a 25,000 square-foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and a state of the art commercial kitchen that will produce several of the industry’s top performing edible brands. Leveraging its scale and more than 20 years of greenhouse operational excellence, Flower One offers consistent, reliable, high-volume, and just-in-time fulfillment to a growing number of established cannabis brands. The Company is fully licensed for both recreational and medical marijuana cultivation and production in the state of Nevada.

Flower One is the largest cannabis cultivator, producer and full-service brand fulfillment partner in the state of Nevada. Flower One's fully operational flagship 400,000 square-foot greenhouse and 55,000 square-foot production facility is used for cannabis cultivation, processing, production and manufacturing of dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals and infused products. The Company also operates a 25,000 square-foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and a state of the art commercial kitchen that will produce several of the industry’s top performing edible brands. Leveraging its scale and more than 20 years of greenhouse operational excellence, Flower One offers consistent, reliable, high-volume, and just-in-time fulfillment to a growing number of established cannabis brands. The Company is fully licensed for both recreational and medical marijuana cultivation and production in the state of Nevada.

Flower One Holdings Inc. - Common Shares

Each Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the issue date and prior to the expiry time, to acquire one (1) Common Share upon payment of the Exercise Price of $0.36.

See the Warrant Indenture for full details.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-09-14-Terry-Fox-Website.jpg

Terry Fox Virtual Run

Friday, September 17, 2021 to Sunday, September 19, 2021
Richard_Carleton_Website.png

Business of Cannabis: New York

Wednesday, September 29, 2021 -
9:00am to 7:00pm
2021-09-20-Digital-Securities-in-the-Capital-Markets_Website.jpg

Digital Securities in the Capital Markets

Wednesday, October 6, 2021 -
2:00pm to 4:00pm

Advertisement

Publicité